Search - tctmd.com

Displaying 81 - 87 of 87

Sort: Relevancy | Date

12-Month Clinical Outcomes of K-Clip® System Transcatheter Tricuspid Annuloplasty Multicenter Pivotal Trial

Presentation NY Valves 2024

12-Month Clinical Outcomes of K-Clip® System Transcatheter Tricuspid Annuloplasty Multicenter Pivotal Trial

Presenter: Guangyuan Song

June 05, 2024

First-in-Human Clinical Trial of a Robotic TEE System for Diagnostics and Interventional Guidance (ROB'E)

Presentation NY Valves 2024

First-in-Human Clinical Trial of a Robotic TEE System for Diagnostics and Interventional Guidance (ROB'E)

Presenter: Jury Schewel

June 05, 2024

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Presentation NY Valves 2024

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Presenter: Rebecca T. Hahn

June 05, 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presentation NY Valves 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presenter: Neel Butala

June 05, 2024

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

Presentation NY Valves 2024

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

Presenter: Howard C. Herrmann

June 05, 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

Video

» Interview

New Tricuspid Therapies: From Clinical Trial to Clinical Practice

June 26, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.